Valerie M Weaver

Title: Valerie M Weaver: Innovator in Cancer Treatment

Introduction

Valerie M Weaver is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer research, particularly in the development of methods for predicting and treating drug-resistant tumors. With a total of 4 patents to her name, her work is paving the way for advancements in oncology.

Latest Patents

One of her latest patents focuses on methods for predicting and treating tumors that are resistant to drugs, immunotherapy, and radiation. This invention relates to the prognosis, diagnosis, and treatment of malignant tumors that exhibit treatment resistance. The methods provided in this patent involve the detection of expression levels of nuclear co-repressor 2 (N-CoR2) and histone deacetylases 3 (HDAC3), along with their associated gene expression biomarkers. Additionally, the invention offers strategies for sensitizing tumors to anti-tumor therapeutics by disrupting HDAC3 activation and inhibiting the activity of either protein.

Career Highlights

Valerie M Weaver is affiliated with the University of California, where she continues her research and innovation in cancer treatment. Her work has garnered attention for its potential to improve patient outcomes in oncology.

Collaborations

Throughout her career, Valerie has collaborated with notable researchers, including Mina J Bissell and Kun-Chih Kelvin Tsai. These collaborations have further enriched her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Valerie M Weaver stands out as a leading inventor in the field of cancer research, with her innovative approaches to treating drug-resistant tumors. Her contributions are vital in the ongoing battle against cancer, and her work continues to inspire future advancements in medical science.